Condition: Hematologic Diseases · Neoplasms · Sponsor: Zhejiang University
This is an open-label, single-arm clinical study designed to evaluate the efficacy and safety of IL-5 CAR-T cell therapy in the treatment of patients with CD125-positive eosinophilic leukemia.
This description comes directly from the study's public registry record.
Songmin Ying, MD · 0571-88208002 · yings@zju.edu.cn
Yongxian Hu, MD · 057187233772 · huyongxian2000@aliyun.com
Always discuss trial participation with your own doctor first.
| The first affiliated hospital of medical college of zhejiang university | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07257640